Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial
Top Cited Papers
- 9 July 2015
- journal article
- research article
- Published by Elsevier in The Lancet HIV
- Vol. 2 (8) , e319-e327
- https://doi.org/10.1016/s2352-3018(15)00114-9
Abstract
No abstract availableKeywords
Funding Information
- Merck Sharp and Dohme
This publication has 20 references indexed in Scilit:
- Virologic Response Following Combined Ledipasvir and Sofosbuvir Administration in Patients With HCV Genotype 1 and HIV Co-infectionJAMA, 2015
- HIV and hepatitis C co-infection in Europe, Israel and Argentina: a EuroSIDA perspectiveBMC Infectious Diseases, 2014
- Deaths Among People With Hepatitis C in New York City, 2000-2011Clinical Infectious Diseases, 2014
- Fibrosis progression in human immunodeficiency virus/hepatitis C virus coinfected adults: Prospective analysis of 435 liver biopsy pairsHepatology, 2013
- Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV?Journal of Hepatology, 2013
- HIV Coinfection With Hepatitis C Virus: Evolving Epidemiology and Treatment ParadigmsClinical Infectious Diseases, 2012
- HIV and viral hepatitis coinfections: advances and challengesGut, 2012
- Spontaneous Viral Clearance, Viral Load, and Genotype Distribution of Hepatitis C Virus (HCV) in HIV‐Infected Patients with Anti‐HCV Antibodies in EuropeThe Journal of Infectious Diseases, 2008
- Viral Hepatitis in HIV InfectionNew England Journal of Medicine, 2007
- Hepatitis C Virus Infection–Related Morbidity and Mortality among Patients with Human Immunodeficiency Virus InfectionClinical Infectious Diseases, 2001